NEW DOT DRUG TESTING REGULATIONS EFFECTIVE 01-01-2018
Post date: Mar 6, 2018 4:03:30 PM
ACT NOW: Important drug testing changes
Changes to the U.S. Department of Transportation (DOT) drug-testing regulations took effect January 1, 2018 and already we are seeing a major impact. The percentage of laboratory positive tests has doubled and the number of safety warnings issued by the MRO has gone up even more. If you act now, there are ways to keep your workplace safer, avoid positive tests and prevent employees from being removed due to safety letters.
Four New Opioids, a Change from "Opiates" to "Opioids" and a delay in safety warnings
Effective January 1, 2018, the Final Rule added four semi-synthetic opioids to DOT's standard 5-panel drug
testing: hydrocodone; hydromorphone; oxymorphone; and oxycodone. In addition, the regulations rename the category or class of drugs currently referred to as " opiates" to "opioids."
Medical Review Officers (M RO' s) always issued safety warnings to employers when the MRO learned of information during the post -drug test interview with the employee/ urine donor that would likely lead to the employee being medically disqualified . What is new is the "5 day pause." The employee has 5 business days to have his or her physician contact the MRO to discuss the safety issue. For example, if an employee tests positive for oxycodone and presents a prescription to the MRO, the MRO would tell the employee that there is a potential safety issue and that the employee has 5 business days to have the prescribing physician contact the MRO to discuss. After 5 days or after the discussion takes place, whichever comes first, the MRO will then report the safety issue to the employer if the issue cannot be resolved.